
Travis Sloan Chambers
Examiner (ID: 5702, Phone: (571)272-6813 , Office: P/2831 )
| Most Active Art Unit | 2831 |
| Art Unit(s) | 2839, 2831, 2833 |
| Total Applications | 1595 |
| Issued Applications | 1356 |
| Pending Applications | 75 |
| Abandoned Applications | 200 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7097810
[patent_doc_number] => 20050130269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 10/501071
[patent_app_country] => US
[patent_app_date] => 2003-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8614
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130269.pdf
[firstpage_image] =>[orig_patent_app_number] => 10501071
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/501071 | Fusion proteins | Jan 9, 2003 | Issued |
Array
(
[id] => 902728
[patent_doc_number] => 07335490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-26
[patent_title] => 'Use of erythropoietin for the preventive or curative treatment of cardiac failure'
[patent_app_type] => utility
[patent_app_number] => 10/500913
[patent_app_country] => US
[patent_app_date] => 2003-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6409
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/335/07335490.pdf
[firstpage_image] =>[orig_patent_app_number] => 10500913
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/500913 | Use of erythropoietin for the preventive or curative treatment of cardiac failure | Jan 8, 2003 | Issued |
Array
(
[id] => 935510
[patent_doc_number] => 06974860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-13
[patent_title] => 'Target recognizing binding agents'
[patent_app_type] => utility
[patent_app_number] => 10/335181
[patent_app_country] => US
[patent_app_date] => 2002-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 28
[patent_no_of_words] => 27886
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/974/06974860.pdf
[firstpage_image] =>[orig_patent_app_number] => 10335181
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/335181 | Target recognizing binding agents | Dec 29, 2002 | Issued |
Array
(
[id] => 5710947
[patent_doc_number] => 20060052292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Adiponectin fragments and conjugates'
[patent_app_type] => utility
[patent_app_number] => 10/498665
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 73595
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052292.pdf
[firstpage_image] =>[orig_patent_app_number] => 10498665
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/498665 | Adiponectin fragments and conjugates | Dec 19, 2002 | Abandoned |
Array
(
[id] => 6797454
[patent_doc_number] => 20030176328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Adiponectin fragments and conjugates'
[patent_app_type] => new
[patent_app_number] => 10/325717
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 74109
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176328.pdf
[firstpage_image] =>[orig_patent_app_number] => 10325717
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/325717 | Adiponectin fragments and conjugates | Dec 19, 2002 | Abandoned |
Array
(
[id] => 7105791
[patent_doc_number] => 20050107598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'C-type lectin polypeptide, polynucleotide and methods of making and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/499184
[patent_app_country] => US
[patent_app_date] => 2002-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 32649
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107598.pdf
[firstpage_image] =>[orig_patent_app_number] => 10499184
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/499184 | C-type lectin polypeptides | Dec 18, 2002 | Issued |
Array
(
[id] => 7022274
[patent_doc_number] => 20050016676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Method and kit providing bioadhesive binding or coating with polyphenolic mussel proteins'
[patent_app_type] => utility
[patent_app_number] => 10/498793
[patent_app_country] => US
[patent_app_date] => 2002-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4148
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20050016676.pdf
[firstpage_image] =>[orig_patent_app_number] => 10498793
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/498793 | Method and kit providing bioadhesive binding or coating with polyphenolic mussel proteins | Dec 12, 2002 | Issued |
Array
(
[id] => 7413125
[patent_doc_number] => 20040106779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-03
[patent_title] => 'Modified factor IX preparation'
[patent_app_type] => new
[patent_app_number] => 10/309877
[patent_app_country] => US
[patent_app_date] => 2002-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4207
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20040106779.pdf
[firstpage_image] =>[orig_patent_app_number] => 10309877
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/309877 | Modified factor IX preparation | Dec 2, 2002 | Abandoned |
Array
(
[id] => 6634302
[patent_doc_number] => 20030211538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'CAP-Gly domain structure and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/309763
[patent_app_country] => US
[patent_app_date] => 2002-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 29977
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211538.pdf
[firstpage_image] =>[orig_patent_app_number] => 10309763
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/309763 | CAP-Gly domain structure and uses thereof | Dec 2, 2002 | Abandoned |
Array
(
[id] => 6792482
[patent_doc_number] => 20030087826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Conjugates comprising two active agents'
[patent_app_type] => new
[patent_app_number] => 10/302428
[patent_app_country] => US
[patent_app_date] => 2002-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4469
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087826.pdf
[firstpage_image] =>[orig_patent_app_number] => 10302428
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/302428 | Conjugates comprising two active agents | Nov 21, 2002 | Issued |
Array
(
[id] => 7429567
[patent_doc_number] => 20040001832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Alstroem syndrome gene, gene variants, expressed protein and methods of diagnosis for Alstroem syndrome'
[patent_app_type] => new
[patent_app_number] => 10/292576
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4508
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20040001832.pdf
[firstpage_image] =>[orig_patent_app_number] => 10292576
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/292576 | Alstroem syndrome gene, gene variants, expressed protein and methods of diagnosis for Alstroem syndrome | Nov 11, 2002 | Abandoned |
Array
(
[id] => 6855578
[patent_doc_number] => 20030129079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Method for protein-preserving purification of contaminated biological liquids'
[patent_app_type] => new
[patent_app_number] => 10/278814
[patent_app_country] => US
[patent_app_date] => 2002-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1158
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129079.pdf
[firstpage_image] =>[orig_patent_app_number] => 10278814
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/278814 | Method for protein-preserving purification of contaminated biological liquids | Oct 23, 2002 | Abandoned |
Array
(
[id] => 6765597
[patent_doc_number] => 20030099996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'VELP2, a vascular endothelial cell specific and LIM domain containing molecule and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/273680
[patent_app_country] => US
[patent_app_date] => 2002-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40244
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20030099996.pdf
[firstpage_image] =>[orig_patent_app_number] => 10273680
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/273680 | VELP2, a vascular endothelial cell specific and LIM domain containing molecule and uses therefor | Oct 17, 2002 | Abandoned |
Array
(
[id] => 793030
[patent_doc_number] => 06982075
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-03
[patent_title] => 'Use of pulmonary surfactant'
[patent_app_type] => utility
[patent_app_number] => 10/491961
[patent_app_country] => US
[patent_app_date] => 2002-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3407
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/982/06982075.pdf
[firstpage_image] =>[orig_patent_app_number] => 10491961
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/491961 | Use of pulmonary surfactant | Oct 9, 2002 | Issued |
Array
(
[id] => 707374
[patent_doc_number] => 07060460
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-13
[patent_title] => 'Method for reconstituting a recombinant protein to its biologically active form'
[patent_app_type] => utility
[patent_app_number] => 10/261508
[patent_app_country] => US
[patent_app_date] => 2002-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8433
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/060/07060460.pdf
[firstpage_image] =>[orig_patent_app_number] => 10261508
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/261508 | Method for reconstituting a recombinant protein to its biologically active form | Oct 1, 2002 | Issued |
Array
(
[id] => 7211746
[patent_doc_number] => 20050054037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Ferroportin-1 mutant'
[patent_app_type] => utility
[patent_app_number] => 10/490795
[patent_app_country] => US
[patent_app_date] => 2002-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10001
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054037.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490795
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490795 | Ferroportin-1 mutant | Sep 30, 2002 | Abandoned |
Array
(
[id] => 6684178
[patent_doc_number] => 20030120042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Process for producing recombinant protein'
[patent_app_type] => new
[patent_app_number] => 10/240295
[patent_app_country] => US
[patent_app_date] => 2002-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10292
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20030120042.pdf
[firstpage_image] =>[orig_patent_app_number] => 10240295
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/240295 | Process for producing recombinant protein | Sep 26, 2002 | Abandoned |
Array
(
[id] => 7226615
[patent_doc_number] => 20040072990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Antimicrobial peptides with reduced hemolysis and methods of their use'
[patent_app_type] => new
[patent_app_number] => 10/247476
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3510
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072990.pdf
[firstpage_image] =>[orig_patent_app_number] => 10247476
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/247476 | Antimicrobial peptides with reduced hemolysis and methods of their use | Sep 19, 2002 | Abandoned |
Array
(
[id] => 6851379
[patent_doc_number] => 20030143582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Human CDC4 modulates cyclin E degradation'
[patent_app_type] => new
[patent_app_number] => 10/245618
[patent_app_country] => US
[patent_app_date] => 2002-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23407
[patent_no_of_claims] => 155
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143582.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245618
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245618 | Human CDC4 modulates cyclin E degradation | Sep 15, 2002 | Abandoned |
Array
(
[id] => 985396
[patent_doc_number] => 06924124
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-08-02
[patent_title] => 'Feeding strategies for cell culture'
[patent_app_type] => utility
[patent_app_number] => 10/227154
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5880
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/924/06924124.pdf
[firstpage_image] =>[orig_patent_app_number] => 10227154
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/227154 | Feeding strategies for cell culture | Aug 22, 2002 | Issued |